CS logo
small CS logo
Aspirus Regional Cancer Center

Wausau, Wisconsin, United States
Oncologist in Wausau, Wisconsin
215 N 28th Ave, Wausau, WI 54401

About Aspirus Regional Cancer Center


"Aspirus is a non-profit, community-directed health system based in Wausau, Wisconsin. Its 7,700 employees are focused on improving the health and well-being of people throughout Wisconsin and Upper Michigan. Aspirus serves communities through four hospitals in Upper Michigan and four hospitals in Wisconsin, more than 50 clinics, home health and hospice care, pharmacies, critical care and air-medical transport, medical goods, nursing homes and a broad network of physicians. Aspirus was recognized by IBM Watson Health as a Top 15 Health System in its 2018 annual study identifying the top-performing health systems in the country."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
63
SWOG Cancer Research Network
33
Alliance for Clinical Trials in Oncology
27
NRG Oncology
14
Radiation Therapy Oncology Group
13
ECOG-ACRIN Cancer Research Group
11
NSABP Foundation Inc
8
Eastern Cooperative Oncology Group
7
ETOP IBCSG Partners Foundation
2
Gynecologic Oncology Group
2
Sanofi
2
Total Rows: 19

Clinical Trials at Aspirus Regional Cancer Center


During the past decade, Aspirus Regional Cancer Center conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 85 clinical trials were completed, i.e. on average, 111.8% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 39 clinical trials were completed. i.e. 177.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11116699991919121210106610101010991111881616Started TrialsCompleted Trails201520162017201820192020202101020
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
1998-10-01
2004-10-01
Completed
1,691
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
2000-06-01
2018-05-14
Completed
230
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
2000-10-01
Unknown status
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
2000-12-01
2008-10-01
Completed
Combination Chemotherapy in Treating Patients With Bladder Cancer
2004-03-01
2009-04-01
Completed
42
Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
2001-07-01
2005-04-01
Completed

Rows per page:

1–100 of 191

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Aspirus Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 63 trials, followed by "SWOG Cancer Research Network" with 33 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "NRG Oncology" with 14 trials sponsored and "Radiation Therapy Oncology Group" with 14 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Aspirus Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 118 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "Cancer and Leukemia Group B" with 8 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 41 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 63National CancerInstitute (NCI): 63SWOG Cancer ResearchNetwork: 33SWOG Cancer ResearchNetwork: 33Alliance for ClinicalTrials in Oncology: 27Alliance for ClinicalTrials in Oncology: 27NRG Oncology: 14NRG Oncology: 14Radiation TherapyOncology Group: 13Radiation TherapyOncology Group: 13ECOG-ACRIN CancerResearch Group: 11ECOG-ACRIN CancerResearch Group: 11NSABP Foundation Inc: 8NSABP Foundation Inc: 8Eastern CooperativeOncology Group: 7Eastern CooperativeOncology Group: 7ETOP IBCSG PartnersFoundation: 2ETOP IBCSG PartnersFoundation: 2Gynecologic Oncology Group: 2Gynecologic Oncology Group: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 118National CancerInstitute (NCI): 118NRG Oncology: 28NRG Oncology: 28NCIC Clinical Trials Group: 9NCIC Clinical Trials Group: 9SWOG Cancer ResearchNetwork: 9SWOG Cancer ResearchNetwork: 9Cancer and LeukemiaGroup B: 8Cancer and LeukemiaGroup B: 8Eastern CooperativeOncology Group: 7Eastern CooperativeOncology Group: 7North Central CancerTreatment Group: 7North Central CancerTreatment Group: 7Radiation TherapyOncology Group: 7Radiation TherapyOncology Group: 7Canadian Cancer Trials Group: 5Canadian Cancer Trials Group: 5American College ofSurgeons: 2American College ofSurgeons: 2

Clinical Trials Conditions at Aspirus Regional Cancer Center


According to Clinical.Site data, the most researched conditions in "Aspirus Regional Cancer Center" are "Breast Cancer" (16 trials), "Colorectal Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Prostate Cancer" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Aspirus Regional Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Aspirus Regional Cancer Center


Most popular intervention types in "Aspirus Regional Cancer Center" are "Drug" (152 trials), "Other" (106 trials), "Biological" (72 trials), "Radiation" (50 trials) and "Procedure" (35 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (50 trials), "Quality-of-Life Assessment" (49 trials), "Questionnaire Administration" (24 trials), "Bevacizumab" (18 trials) and "Paclitaxel" (18 trials). Other intervention names were less common.

Clinical Trials Genders at Aspirus Regional Cancer Center


The vast majority of trials in "Aspirus Regional Cancer Center" are 140 trials for "All" genders, 34 trials for "Female" genders and 17 trials for "Male" genders.

Clinical Trials Status at Aspirus Regional Cancer Center


Currently, there are NaN active trials in "Aspirus Regional Cancer Center". undefined are not yet recruiting, 36 are recruiting, 82 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in Aspirus Regional Cancer Center, 4 suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Aspirus Regional Cancer Center, 2 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 129 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 129Phase 3: 129Phase 2: 64Phase 2: 64Not Applicable: 8Not Applicable: 8Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 82Active, not recruiting: 82Completed: 61Completed: 61Recruiting: 36Recruiting: 36Terminated: 7Terminated: 7Suspended: 4Suspended: 4Unknown status: 1Unknown status: 1